These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2831127)
1. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin). Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127 [TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia. Pappu AS; Illingworth DR J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708 [TBL] [Abstract][Full Text] [Related]
4. The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia. Illingworth DR; Corbin D Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6291-4. PubMed ID: 2994068 [TBL] [Abstract][Full Text] [Related]
5. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
6. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. Farnsworth WH; Hoeg JM; Maher M; Brittain EH; Sherins RJ; Brewer HB J Clin Endocrinol Metab; 1987 Sep; 65(3):546-50. PubMed ID: 3114306 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia. McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649 [TBL] [Abstract][Full Text] [Related]
8. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway. Laue L; Hoeg JM; Barnes K; Loriaux DL; Chrousos GP J Clin Endocrinol Metab; 1987 Mar; 64(3):531-5. PubMed ID: 3029155 [TBL] [Abstract][Full Text] [Related]
9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
10. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Illingworth DR; Bacon S Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189 [TBL] [Abstract][Full Text] [Related]
11. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes. Cuthbert JA; Lipsky PE Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of low-dose lovastatin in lowering serum cholesterol. Experience with 56 patients. Bates MC; Warren SG; Grubb S; Chillag S Arch Intern Med; 1990 Sep; 150(9):1947-50. PubMed ID: 2393325 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V; Harvengt C Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098 [TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. Illingworth DR; Sexton GJ J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064 [TBL] [Abstract][Full Text] [Related]
15. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia. Prihoda JS; Pappu AS; Smith FE; Illingworth DR J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705 [TBL] [Abstract][Full Text] [Related]
16. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]. Stugaard M; Wiig I; Lund H; Ose L; Norseth J Tidsskr Nor Laegeforen; 1992 Aug; 112(20):2642-6. PubMed ID: 1412289 [TBL] [Abstract][Full Text] [Related]
17. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia. Cuthbert JA; Lipsky PE Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Thompson GR; Ford J; Jenkinson M; Trayner I Q J Med; 1986 Aug; 60(232):803-11. PubMed ID: 3640503 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. Grundy SM; Bilheimer DW Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816 [TBL] [Abstract][Full Text] [Related]
20. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients. Wallace MB; Warren SG; Bates MC; Robinson PA W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]